Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Oleg Kolupaev"'
Autor:
Karen McKinnon, Kristen Cowens, Dante Bortone, Lisa Carey, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, Carey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A Cuaboy, Amy L Garrett, Benjamin C Calhoun, Alec D Wilkinson, E Claire Dees, Benjamin G Vincent, Jonathan S Serody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/4b4477f689454bc2b5fe6bd317c412e0
Autor:
Mostafa Yazdimamaghani, Oleg Kolupaev, Chaemin Lim, Duhyeong Hwang, Alexander Kabanov, Jonathan Serody
Publikováno v:
Cancer Research. 83:1810-1810
Triple-negative breast cancer (TNBC) is characterized by high cell proliferation, abundant heterogeneity, frequent incidence of lung and brain metastases, repeated disease recurrence, and the worst prognosis among all breast cancer subtypes. Extensiv
Publikováno v:
Blood. 140:10231-10232
Publikováno v:
Blood. 140:10208-10208
Publikováno v:
J Immunol
We have previously shown in a model of claudin-low breast cancer that regulatory T cells (Tregs) are increased in the tumor microenvironment (TME) and express high levels of PD-1. In mouse models and patients with triple-negative breast cancer, it is
Autor:
Hemamalini Bommiasamy, Jonathan S. Serody, James M. Coghill, Bruce R. Blazar, Oleg Kolupaev, Danny W. Bruce, Heather E. Stefanski
Publikováno v:
Blood. 134:3205-3205
Donor T cells present in the stem cell or bone marrow inoculum are critical to the induction of acute graft-versus-host disease (aGvHD). AGvHD of the gastrointestinal (GI) tract that is non-responsive to corticosteroid therapy is significant problem
Autor:
James M. Coghill, Jonathan S. Serody, Michelle L. West, Stephen L. Tilley, Bruce R. Blazar, Oleg Kolupaev
Publikováno v:
Blood. 126:1883-1883
Background. Chronic-graft-versus-host disease (cGvHD) continues to be a major complication following allogeneic hematopoietic stem cell transplantation (HSCT). Despite significant progress, mechanisms underlying development of the pathology are yet t